NCT06554925 SEx-specific Differences in Cardiac Surgery Patients (SECS).
| NCT ID | NCT06554925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jennifer Breel |
| Condition | Female |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2030-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2022-03-01 with a primary completion date of 2030-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the differences between females and males undergoing cardiac surgery. The investigators will look at perioperative factors such as adaption of body weight, previous medical history, pharmacokinetics, transfusion, coagulation, cardiopulmonary bypass (CPB) related factors, cardiac function, inotropic requirements, risk, and outcome scores as well as morbidity and mortality at sort-term (within 30 days) and long-term (90 days and 1 year).
Eligibility Criteria
Inclusion Criteria: * Patients \> 18 years * All patients who underwent cardiac surgery from 1 January 1998 in the AUMC, location VUmc, until 1 June 2021. Exclusion Criteria: * None
Contact & Investigator
Markus W Hollmann, Professor
PRINCIPAL INVESTIGATOR
Anesthesiology and Pain Medicine, Amsterdam Medical Center
Frequently Asked Questions
Who can join the NCT06554925 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06554925 currently recruiting?
Yes, NCT06554925 is actively recruiting participants. Contact the research team at j.s.breel@amsterdamumc.nl for enrollment information.
Where is the NCT06554925 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands.
Who is sponsoring the NCT06554925 clinical trial?
NCT06554925 is sponsored by Jennifer Breel. The principal investigator is Markus W Hollmann, Professor at Anesthesiology and Pain Medicine, Amsterdam Medical Center. The trial plans to enroll 10,000 participants.